Bristol-Myers Squibb

BMS nabs EU approval for once-daily HIV combo pill
BioPharma Dive
Sat, 07/18/15 - 10:31 am
Bristol-Myers Squibb
Europe
HIV
Evotaz
What Will Gilead Buy Next? 4 Possible Targets
Investors.com
Wed, 07/15/15 - 06:30 pm
Gilead Sciences
M&A
Incyte
Vertex Pharmaceuticals
Bristol-Myers Squibb
Achillion
BMS snares 'Modern Family' star to raise flag for immuno-oncology awareness
Fierce Pharma Marketing
Wed, 07/15/15 - 11:24 am
Bristol-Myers Squibb
endorsements
immuno-oncology
How does the Keytruda-Opdivo marketing battle stack up?
Fierce Pharma Marketing
Mon, 07/13/15 - 11:05 am
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
cancer immunotherapy
Bayer, J&J touting Xarelto trial data to counteract Eliquis surge
Fierce Pharma Marketing
Tue, 06/30/15 - 11:30 am
Bayer
JNJ
Xarelto
clinical trial data
bloodthinners
Eliquis
Pfizer
Bristol-Myers Squibb
Should Bristol-Myers cut payer deals to boost melanoma combo over one-drug treatments?
Fierce Pharma Marketing
Mon, 06/29/15 - 11:32 am
melanoma
Bristol-Myers Squibb
payer negotiation
Yervoy
Opdivo
Bristol-Myers is the next big tenant in biotech's hottest neighborhood
Fierce Biotech
Fri, 06/26/15 - 11:47 am
Bristol-Myers Squibb
R&D
Cambridge MA
Bristol-Myers' Opdivo is approved as a skin cancer treatment in Europe
Yahoo/AP
Fri, 06/19/15 - 05:44 pm
Bristol-Myers Squibb
Opdivo
Europe
skin cancer
Autoimmune Drugs to Drive Big Pharma Higher in Coming Years
24/7 Wall St
Mon, 06/8/15 - 09:58 pm
autoimmune disease
AbbVie
JNJ
Eli Lilly
Merck
Bristol-Myers Squibb
Pfizer
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
Fri, 06/5/15 - 07:13 pm
ASCO
Ignyta
Immunogen
Puma Biotechnology
AbbVie
Roche
Bristol-Myers Squibb
Seattle Genetics
Juno Therapeutics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
biotech
ASCO
Bristol-Myers Squibb
Immunogen
Oncothyreon
Clovis Oncology
CTI BioPharma
Exelixis
Roche
Amgen
AstraZeneca
Puma Biotechnology
Vascular Biogenics
Immunomedics
Momenta
Eli Lilly
Juno Therapeutics
Express Scripts
The 4 Overlooked Winners of ASCO
24/7 Wall St
Tue, 06/2/15 - 09:12 am
ASCO
Bristol-Myers Squibb
AbbVie
Aveo Pharmaceuticals
Ignyta
The Biggest Selling Cancer Drugs In 2020 Show Significant Change Expected In Five Short Years
Forbes
Mon, 06/1/15 - 11:34 pm
ASCO
PDL-1 inhibitors
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
ASCO
Oncothyreon
Immunogen
Bristol-Myers Squibb
Merck
Clovis Oncology
Roche
CTI BioPharma
Celldex Therapeutics
Puma Biotechnology
Express Scripts
At ASCO: Bristol-Myers Rises on More Data About Cancer Drug
Barron's
Mon, 06/1/15 - 07:11 pm
ASCO
Bristol-Myers Squibb
Opdivo
Bristol-Myers Sues a Former Oncology Exec for Leaving for AstraZeneca
WSJ Pharmalot
Mon, 06/1/15 - 07:06 pm
Bristol-Myers Squibb
AstraZeneca
ASCO 15: The top 10 setbacks, advances and head scratchers
Fierce Biotech
Mon, 06/1/15 - 12:15 pm
ASCO
Celldex Therapeutics
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Clovis Oncology
AstraZeneca
Genentech
Pairing of Two Bristol-Myers Drugs Sees Success in Battling Skin Cancer, Study Says
WSJ Online
Sun, 05/31/15 - 11:23 am
Bristol-Myers Squibb
Opdivo
Yervoy
Your ASCO15 guide: A mixed bag for Bristol-Myers, big wins for Merck, J&J
BioPharma Dive
Sun, 05/31/15 - 11:21 am
ASCO
Bristol-Myers Squibb
JNJ
Merck
Keytruda
Opdivo
daratumumab
Bristol-Myers Slumps as Cancer Drug Trial Results Disappoint
Bloomberg
Fri, 05/29/15 - 05:50 pm
Bristol-Myers Squibb
Opdivo
lung cancer

Pages